Technical Articles
Targeted protein
Precisely Driving PROTAC Development: Human BCL6/CRBN Molecular Glue Binding Detection Kit
In the field of targeted protein degradation, particularly in the development of molecular glue drugs targeting the critical transcription factor BCL6, how to rapidly and accurately quantify the efficiency of ternary complex formation induced by candidate compounds is a key step in accelerating lead compound discovery and optimization.
View details
- Signaling Pathway
- Targeted protein
- transcription factor BCL6
- ternary complex.
Precisely Driving PROTAC Development: Human BCL6/CRBN Molecular Glue Binding Detection Kit
In the field of targeted protein degradation, particularly in the development of molecular glue drugs targeting the critical transcription factor BCL6, rapidly and accurately quantifying the efficiency of ternary complex formation induced by candidate compounds is a key step to accelerate lead compound discovery and optimization.
View details
- Cancer
- Targeted protein
- BCL6/CRBN
- PROTAC.
- 1














